BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31679220)

  • 21. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer and Cancer Stem Cells: New Molecular Perspectives.
    Gurel C; Inetas G; Hortu I; Tunc E; Kuscu GC; Dindaroglu FC; Sahin O; Buhur A; Oktem G
    Crit Rev Oncog; 2019; 24(1):99-104. PubMed ID: 31679224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
    Malhi S; Gu X
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer stem cells: the promise and the potential.
    Ajani JA; Song S; Hochster HS; Steinberg IB
    Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration.
    Berretta M; Romano C; Di Francia R; De Diviitis C; Canzonieri V; Caraglia M; Facchini G; Nasti G
    Curr Cancer Drug Targets; 2018; 18(5):430-441. PubMed ID: 28183250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in Cancer Stem Cell Targeted Therapy.
    Akbulut H; Babahan C; Abgarmi SA; Ocal M; Besler M
    Crit Rev Oncog; 2019; 24(1):1-20. PubMed ID: 31679215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
    Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
    Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of MAML1 in targeted therapy against the esophageal cancer stem cells.
    Moghbeli M; Mosannen Mozaffari H; Memar B; Forghanifard MM; Gholamin M; Abbaszadegan MR
    J Transl Med; 2019 Apr; 17(1):126. PubMed ID: 30992079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells as a therapeutic target in bladder cancer.
    Aghaalikhani N; Rashtchizadeh N; Shadpour P; Allameh A; Mahmoodi M
    J Cell Physiol; 2019 Apr; 234(4):3197-3206. PubMed ID: 30471107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
    Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
    Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolving concept of liver cancer stem cells.
    Nio K; Yamashita T; Kaneko S
    Mol Cancer; 2017 Jan; 16(1):4. PubMed ID: 28137313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cells: a challenging paradigm for designing targeted drug therapies.
    Khan IN; Al-Karim S; Bora RS; Chaudhary AG; Saini KS
    Drug Discov Today; 2015 Oct; 20(10):1205-16. PubMed ID: 26143148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
    Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives.
    López-Gómez M; Casado E; Muñoz M; Alcalá S; Moreno-Rubio J; D'Errico G; Jiménez-Gordo AM; Salinas S; Sainz B
    Crit Rev Oncol Hematol; 2016 Nov; 107():54-71. PubMed ID: 27823652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance.
    Qiu GZ; Sun W; Jin MZ; Lin J; Lu PG; Jin WL
    Pharmacol Ther; 2017 Apr; 172():127-138. PubMed ID: 27919796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
    Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.